Robotic surgical platform developer Titan Medical Inc. said today it closed a $25 million public offering. Titan Medical said that it floated approximately 7.4 million units in the offering at a price of $3.40 per unit. Each unit offered included a single common share of the Toronto-based company and a warrant for an additional common share…
Titan Medical closes $2m deal with Chinese investor
Titan Medical (TSX:TMD) said today that it closed a deal with Longtai Medical to convert a $2.0 million distributorship deposit to equity. The move makes Longtai the robotic surgical company’s largest shareholder. In May of 2015, Titan Medical and Longtai, a subsidiary of Chinese medical device distributor Ningbo Long Hengtai International Trade Co., inked a deal to…
Titan Medical adds $1m to offering
Titan Medical (TSX:TMD) today announced the 2nd closing of a public offering of shares, bringing in an additional $1.3 million (CDN $1.7 million) on top of a previously raised $5.7 million (CDN $7.3 million) for a total of $7.1 million (CDN $8.9 million). The Toronto-based surgical robotics company said it sold an additional 11.1 million shares…
Titan Medical finds partner for Sport robotic platform feasibility, validation studies
Titan Medical (TSX:TMD) said today it inked a collaborative deal with Florida Hospital Nicholson Center to engage in a feasibility and validation study of Titan’s Sport robotic surgical system as the company seeks regulatory approval for the platform. The Toronto-based robotic surgical system developer said it expects to commence the studies in the 4th quarter, with…
Titan Medical closes $6m offering
Titan Medical (TSX:TMD) said today that it raised nearly $6 million in a public offering, with company insiders putting up another $166,000. Toronto-based Titan, which is developing the Sport robot-assisted surgery platform, had said it might float up to 100 million shares, which would have fetched $11.5 million. In the event the company floated nearly 48.4 million shares…
Titan Medical looks to raise up to $12m for Sport surgical robotics platform
Titan Medical (TSX:TMD) said today that it plans to float as many as 100 million shares in a public offering that could fetch as much as $11.5 million for the Sport robot-assisted surgery platform it’s developing. The Toronto-based company said it will offer at least 46.7 million shares at 11.5¢ (C15.0¢) apiece, for minimum gross proceeds of…
Titan Medical shareholders approve reverse split
Titan Medical (CVE:TMD) said today its shareholders approved a reverse stock split. The ratio of shares has yet to be announced, according to a press release, and will be determined by the board of directors of the company in its sole discretion. Toronto-based Titan Medical added that the range of post-consolidation shares will be a single…